Compromised NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Chronic SIV/SHIV Infection

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  He, Xuan ^a,b   Li, Dan ^b   Luo, Zhenwu ^a,b   Liang, Hua ^b   Peng, Hong ^b   Zhao, Yangyang ^b   Wang, Nidan ^b   Liu, Donghua ^b   Qin, Chuan ^c   Wei, Qiang ^c   Yan, Huimin ^a   Shao, Yiming ^b  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD32 ANTIGEN; FC GAMMA RECEPTOR IIIA; FC RECEPTOR; MATRIX METALLOPROTEINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN EXPRESSION; ARTICLE; CELL ASSAY; CELL FUNCTION; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR DYNAMICS; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RHESUS MONKEY; SIGNAL TRANSDUCTION; TARGET CELL;

ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CELL LINE, TUMOR; CHRONIC DISEASE; GENE EXPRESSION REGULATION; HUMANS; KILLER CELLS, NATURAL; MACACA MULATTA; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES; MICE; RECEPTORS, IGG; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84873704484     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056309     Document Type: Article

References (37)

1. Ahmad A, Morisset R, Thomas R, Menezes J, (1994) Evidence for a defect of antibody-dependent cellular cytotoxic (ADCC) effector function and anti-HIV gp120/41-specific ADCC-mediating antibody titres in HIV-infected individuals. J Acquir Immune Defic Syndr 7: 428-437.
2. Forthal DN, Landucci G, Haubrich R, Keenan B, Kuppermann BD, et al. (1999) Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients. J Infect Dis 180: 1338-1341.
3. Forthal DN, Landucci G, Keenan B, (2001) Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4(+) lymphocyte count. Aids Research and Human Retroviruses 17: 553-561.
4. Florese RH, Demberg T, Xiao P, Kuller L, Larsen K, et al. (2009) Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines. J Immunol 182: 3718-3727.
5. Gomez-Roman VR, Patterson LJ, Venzon D, Liewehr D, Aldrich K, et al. (2005) Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251. J Immunol 174: 2185-2189.
6. Florese RH, Van Rompay KK, Aldrich K, Forthal DN, Landucci G, et al. (2006) Evaluation of passively transferred, nonneutralizing antibody-dependent cellular cytotoxicity-mediating IgG in protection of neonatal rhesus macaques against oral SIVmac251 challenge. J Immunol 177: 4028-4036.
7. Sawyer LA, Katzenstein DA, Hendry RM, Boone EJ, Vujcic LK, et al. (1990) Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection. AIDS Res Hum Retroviruses 6: 341-356.
8. Richman DD, Wrin T, Little SJ, Petropoulos CJ, (2003) Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci U S A 100: 4144-4149.
9. Asmal M, Sun Y, Lane S, Yeh W, Schmidt SD, et al. (2011) Antibody-dependent cell-mediated viral inhibition emerges after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys coincident with gp140-binding antibodies and is effective against neutralization-resistant viruses. J Virol 85: 5465-5475.
10. Permar SR, Wilks AB, Ehlinger EP, Kang HH, Mahlokozera T, et al. (2010) Limited contribution of mucosal IgA to Simian immunodeficiency virus (SIV)-specific neutralizing antibody response and virus envelope evolution in breast milk of SIV-infected, lactating rhesus monkeys. J Virol 84: 8209-8218.
11. Sun Y, Asmal M, Lane S, Permar SR, Schmidt SD, et al. (2011) Antibody-dependent cell-mediated cytotoxicity in simian immunodeficiency virus-infected rhesus monkeys. J Virol 85: 6906-6912.
12. Xiao P, Zhao J, Patterson LJ, Brocca-Cofano E, Venzon D, et al. (2010) Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. J Virol 84: 7161-7173.
13. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, et al. (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361: 2209-2220.
14. Liu Q, Sun Y, Rihn S, Nolting A, Tsoukas PN, et al. (2009) Matrix metalloprotease inhibitors restore impaired NK cell-mediated antibody-dependent cellular cytotoxicity in human immunodeficiency virus type 1 infection. J Virol 83: 8705-8712.
15. Choi EI, Reimann KA, Letvin NL, (2008) In vivo natural killer cell depletion during primary simian immunodeficiency virus infection in rhesus monkeys. J Virol 82: 6758-6761.
16. Gomez-Roman VR, Florese RH, Patterson LJ, Peng B, Venzon D, et al. (2006) A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity. J Immunol Methods 308: 53-67.
17. Vargas-Inchaustegui DA, Demberg T, Robert-Guroff M, (2011) A CD8alpha(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities. Immunology 134: 326-340.
18. Pereira LE, Johnson RP, Ansari AA, (2008) Sooty mangabeys and rhesus macaques exhibit significant divergent natural killer cell responses during both acute and chronic phases of SIV infection. Cell Immunol 254: 10-19.
19. Dutertre CA, Bonnin-Gelize E, Pulford K, Bourel D, Fridman WH, et al. (2008) A novel subset of NK cells expressing high levels of inhibitory FcgammaRIIB modulating antibody-dependent function. J Leukoc Biol 84: 1511-1520.
20. Grzywacz B, Kataria N, Verneris MR, (2007) CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases. Leukemia 21: 356-359; author reply 359.
21. Harrison D, Phillips JH, Lanier LL, (1991) Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated Fc gamma RIII (CD16-II). J Immunol 147: 3459-3465.
22. Berman NE, Marcario JK, Yong C, Raghavan R, Raymond LA, et al. (1999) Microglial activation and neurological symptoms in the SIV model of NeuroAIDS: association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changes. Neurobiol Dis 6: 486-498.
23. Mavilio D, Benjamin J, Kim D, Lombardo G, Daucher M, et al. (2005) Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys. Blood 106: 1718-1725.
24. Reeves RK, Gillis J, Wong FE, Yu Y, Connole M, et al. (2010) CD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood 115: 4439-4446.
25. Alter G, Malenfant JM, Altfeld M, (2004) CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294: 15-22.
26. Craston R, Koh M, Mc Dermott A, Ray N, Prentice HG, et al. (1997) Temporal dynamics of CD69 expression on lymphoid cells. J Immunol Methods 209: 37-45.
27. Thobakgale CF, Streeck H, Mkhwanazi N, Mncube Z, Maphumulo L, et al. (2011) Short communication: CD8(+) T cell polyfunctionality profiles in progressive and nonprogressive pediatric HIV type 1 infection. AIDS Res Hum Retroviruses 27: 1005-1012.
28. Boulet S, Song R, Kamya P, Bruneau J, Shoukry NH, et al. (2010) HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells. J Immunol 184: 2057-2064.
29. Wren L, Parsons MS, Isitman G, Center RJ, Kelleher AD, et al. (2012) Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cells. PLoS One 7: e38580.
30. Lichtfuss GF, Meehan AC, Cheng WJ, Cameron PU, Lewin SR, et al. (2011) HIV inhibits early signal transduction events triggered by CD16 cross-linking on NK cells, which are important for antibody-dependent cellular cytotoxicity. J Leukoc Biol 89: 149-158.
31. Mehlhop E, Villamide LA, Frank I, Gettie A, Santisteban C, et al. (2002) Enhanced in vitro stimulation of rhesus macaque dendritic cells for activation of SIV-specific T cell responses. J Immunol Methods 260: 219-234.
32. Hu JL, Van den Steen PE, Sang QXA, Opdenakker G, (2007) Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nature Reviews Drug Discovery 6: 480-498.
33. Sankatsing SU, Jurriaans S, van Swieten P, van Leth F, Cornelissen M, et al. (2004) Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients. Aids 18: 1925-1931.
34. Mastroianni CM, Liuzzi GM, (2007) Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies. Trends Mol Med 13: 449-459.
35. Poonia B, Pauza CD, (2012) Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity. Cytotherapy 14: 173-181.
36. Couzi L, Pitard V, Sicard X, Garrigue I, Hawchar O, et al. (2012) Antibody-dependent anti-cytomegalovirus activity of human gammadelta T cells expressing CD16 (FcgammaRIIIa). Blood 119: 1418-1427.
37. Angelini DF, Borsellino G, Poupot M, Diamantini A, Poupot R, et al. (2004) FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways. Blood 104: 1801-1807.